Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.

Boz C, Terzi M, Özer B, Turkoglu R, Karabudak R, Efendi H, Soysal A, Sevim S, Altintas A, Kurne A, Akçalı A, Akman G, Yüceyar N, Balcı BP, Ekmekci Ö, Karahan SZ, Demirkıran M, Altunrende B, Turan ÖF, Gökçen GözübatıkÇelik, Kale N, Köseoğlu M, Ozakbas S.

Mult Scler Relat Disord. 2019 Aug 26;36:101376. doi: 10.1016/j.msard.2019.101376. [Epub ahead of print]

PMID:
31473488
2.

Susac Syndrome: Clinical characteristics, diagnostic findings and treatment in 19 cases.

Zengin Karahan S, Boz C, Saip S, Kale N, Demirkaya S, Celik Y, Demir S, Kurne A, Ozbek SE, Terzi M.

Mult Scler Relat Disord. 2019 Aug;33:94-99. doi: 10.1016/j.msard.2019.05.018. Epub 2019 May 27.

PMID:
31176296
3.

Coding Family Medicine Residency Clinic Visits, 99213 or 99214? A Residency Research Network of Texas Study.

Young RA, Holder S, Kale N, Burge SK, Kumar KA.

Fam Med. 2019 Jun;51(6):477-483. doi: 10.22454/FamMed.2019.862757. Epub 2019 Apr 23.

4.

Interoperable and scalable data analysis with microservices: Applications in Metabolomics.

Emami Khoonsari P, Moreno P, Bergmann S, Burman J, Capuccini M, Carone M, Cascante M, de Atauri P, Foguet C, Gonzalez-Beltran A, Hankemeier T, Haug K, He S, Herman S, Johnson D, Kale N, Larsson A, Neumann S, Peters K, Pireddu L, Rocca-Serra P, Roger P, Rueedi R, Ruttkies C, Sadawi N, Salek RM, Sansone SA, Schober D, Selivanov V, Thévenot EA, van Vliet M, Zanetti G, Steinbeck C, Kultima K, Spjuth O.

Bioinformatics. 2019 Mar 9. pii: btz160. doi: 10.1093/bioinformatics/btz160. [Epub ahead of print]

PMID:
30851093
5.

Aiming Beyond: A Pharmacist Impact on 90-Day Readmissions and Clinical Outcomes Within a Family Medicine Service.

Wiegmann LE, Belisle MS, Alvarez KS, Kale NJ.

J Pharm Pract. 2019 Feb 25:897190019825970. doi: 10.1177/0897190019825970. [Epub ahead of print]

PMID:
30803312
6.

Minimally Invasive Anterior Two-Incision Approach for Repair of a Chronic Neglected Distal Biceps Tendon Rupture.

Kale AA, Jazrawi LM, Kale NK.

J Orthop Case Rep. 2018 Sep-Oct;8(5):61-66. doi: 10.13107/jocr.2250-0685.1214.

7.

Urine Drug Tests: Ordering and Interpreting Results.

Kale N.

Am Fam Physician. 2019 Jan 1;99(1):33-39.

PMID:
30600984
8.

PhenoMeNal: processing and analysis of metabolomics data in the cloud.

Peters K, Bradbury J, Bergmann S, Capuccini M, Cascante M, de Atauri P, Ebbels TMD, Foguet C, Glen R, Gonzalez-Beltran A, Günther UL, Handakas E, Hankemeier T, Haug K, Herman S, Holub P, Izzo M, Jacob D, Johnson D, Jourdan F, Kale N, Karaman I, Khalili B, Emami Khonsari P, Kultima K, Lampa S, Larsson A, Ludwig C, Moreno P, Neumann S, Novella JA, O'Donovan C, Pearce JTM, Peluso A, Piras ME, Pireddu L, Reed MAC, Rocca-Serra P, Roger P, Rosato A, Rueedi R, Ruttkies C, Sadawi N, Salek RM, Sansone SA, Selivanov V, Spjuth O, Schober D, Thévenot EA, Tomasoni M, van Rijswijk M, van Vliet M, Viant MR, Weber RJM, Zanetti G, Steinbeck C.

Gigascience. 2019 Feb 1;8(2). pii: giy149. doi: 10.1093/gigascience/giy149.

9.

Identifying Patients with Headache Who Are at Risk of Subarachnoid Hemorrhage.

Kale N, Osayande AS.

Am Fam Physician. 2018 Aug 15;98(4):256-257. No abstract available.

10.

The future of metabolomics in ELIXIR.

van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn WB, Ebbels TMD, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia JL, Jimenez RC, Jourdan F, Kale N, Klapa MI, Kohlbacher O, Koort K, Kultima K, Le Corguillé G, Moreno P, Moschonas NK, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek RM, Sansone SA, Satagopam V, Schober D, Shimmo R, Spicer RA, Spjuth O, Thévenot EA, Viant MR, Weber RJM, Willighagen EL, Zanetti G, Steinbeck C.

Version 2. F1000Res. 2017 Sep 6 [revised 2017 Jan 1];6. pii: ELIXIR-1649. doi: 10.12688/f1000research.12342.2. eCollection 2017.

11.

Can a Clinician-Scientist Training Program Develop Academic Orthopaedic Surgeons? One Program's Thirty-Year Experience.

Brandt AM, Rettig SA, Kale NK, Zuckerman JD, Egol KA.

J Surg Educ. 2018 Jul - Aug;75(4):1039-1044. doi: 10.1016/j.jsurg.2017.10.003. Epub 2017 Oct 26.

PMID:
29102560
12.

Automated assembly of species metabolomes through data submission into a public repository.

Salek RM, Conesa P, Cochrane K, Haug K, Williams M, Kale N, Moreno P, Jayaseelan KV, Macias JR, Nainala VC, Hall RD, Reed LK, Viant MR, O'Donovan C, Steinbeck C.

Gigascience. 2017 Aug 1;6(8):1-4. doi: 10.1093/gigascience/gix062.

13.

Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis.

Osayande AS, Kale N.

Am Fam Physician. 2017 Jun 15;95(12):796-797. No abstract available.

14.

Optic neuritis as an early sign of multiple sclerosis.

Kale N.

Eye Brain. 2016 Oct 26;8:195-202. doi: 10.2147/EB.S54131. eCollection 2016. Review.

15.

MetaboLights: An Open-Access Database Repository for Metabolomics Data.

Kale NS, Haug K, Conesa P, Jayseelan K, Moreno P, Rocca-Serra P, Nainala VC, Spicer RA, Williams M, Li X, Salek RM, Griffin JL, Steinbeck C.

Curr Protoc Bioinformatics. 2016 Mar 24;53:14.13.1-18. doi: 10.1002/0471250953.bi1413s53.

PMID:
27010336
16.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ.

Ann Neurol. 2016 May;79(5):775-783. doi: 10.1002/ana.24617. Epub 2016 Apr 4.

17.
18.

ChEBI in 2016: Improved services and an expanding collection of metabolites.

Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C.

Nucleic Acids Res. 2016 Jan 4;44(D1):D1214-9. doi: 10.1093/nar/gkv1031. Epub 2015 Oct 13.

19.

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.

Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF.

Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.

20.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

21.

A large-scale crop protection bioassay data set.

Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP.

Sci Data. 2015 Jul 7;2:150032. doi: 10.1038/sdata.2015.32. eCollection 2015.

22.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

23.

Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.

Tugcu B, Soysal A, Kılıc M, Yuksel B, Kale N, Yıgıt U, Arpaci B.

J Neurol Sci. 2013 Dec 15;335(1-2):182-5. doi: 10.1016/j.jns.2013.09.027. Epub 2013 Oct 1.

PMID:
24148562
24.

Quality of life and anxiety in Turkish patients with anorectal malformation.

Akin Sari B, Demiroğullari B, Ozen O, Iseri E, Kale N, Başaklar C.

J Paediatr Child Health. 2014 Feb;50(2):107-11. doi: 10.1111/jpc.12406. Epub 2013 Oct 18.

PMID:
24134432
25.

OntoQuery: easy-to-use web-based OWL querying.

Tudose I, Hastings J, Muthukrishnan V, Owen G, Turner S, Dekker A, Kale N, Ennis M, Steinbeck C.

Bioinformatics. 2013 Nov 15;29(22):2955-7. doi: 10.1093/bioinformatics/btt514. Epub 2013 Sep 5.

26.

Dovetailing biology and chemistry: integrating the Gene Ontology with the ChEBI chemical ontology.

Hill DP, Adams N, Bada M, Batchelor C, Berardini TZ, Dietze H, Drabkin HJ, Ennis M, Foulger RE, Harris MA, Hastings J, Kale NS, de Matos P, Mungall CJ, Owen G, Roncaglia P, Steinbeck C, Turner S, Lomax J.

BMC Genomics. 2013 Jul 29;14:513. doi: 10.1186/1471-2164-14-513.

27.

The effects of melatonin on intestinal adaptation in a rat model of short bowel syndrome.

Guclu M, Demirogullari B, Barun S, Ozen IO, Karakus SC, Poyraz A, Serdar M, Karabulut R, Türkyılmaz Z, Sönmez K, Kale N, Başaklar A.

Eur J Pediatr Surg. 2014 Apr;24(2):150-7. doi: 10.1055/s-0033-1343081. Epub 2013 Apr 15.

PMID:
23589080
28.

The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013.

Hastings J, de Matos P, Dekker A, Ennis M, Harsha B, Kale N, Muthukrishnan V, Owen G, Turner S, Williams M, Steinbeck C.

Nucleic Acids Res. 2013 Jan;41(Database issue):D456-63. doi: 10.1093/nar/gks1146. Epub 2012 Nov 24.

29.

Impact of Sensor Misplacement on Dynamic Time Warping Based Human Activity Recognition using Wearable Computers.

Kale N, Lee J, Lotfian R, Jafari R.

Proc Wirel Health. 2012 Oct;2012. pii: 7. doi: 10.1145/2448096.2448103.

30.

Management of optic neuritis as a clinically first event of multiple sclerosis.

Kale N.

Curr Opin Ophthalmol. 2012 Nov;23(6):472-6. doi: 10.1097/ICU.0b013e328358b202. Review.

PMID:
23014264
31.

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH.

Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.

32.

Intussusception in children: experience with 105 patients in a department of paediatric surgery, Turkey.

Sonmez K, Turkyilmaz Z, Demirogullari B, Karabulut R, Kale N, Basaklar AC.

S Afr J Surg. 2012 Mar 29;50(2):37-9.

PMID:
22622100
33.

An In Vitro and In Vivo Evaluation of Tensile Strength and Durability of Seven Suture Materials in Various pH and Different Conditions: An Experimental Study in Rats.

Karabulut R, Sonmez K, Turkyilmaz Z, Bagbanci B, Basaklar AC, Kale N.

Indian J Surg. 2010 Oct;72(5):386-90. doi: 10.1007/s12262-010-0158-5. Epub 2010 Nov 23.

34.

Ostomy complicatıons in patients with anorectal malformations.

Demirogullari B, Yilmaz Y, Yildiz GE, Ozen IO, Karabulut R, Turkyilmaz Z, Sonmez K, Basaklar AC, Kale N.

Pediatr Surg Int. 2011 Oct;27(10):1075-8. doi: 10.1007/s00383-011-2955-8.

PMID:
21789666
35.

A rare cause of acute abdomen in children: an intrabiliary rupture of hydatid cyst.

Moralioğlu S, Özen İO, Afşarlar Ç, Karabulut R, Demıroğullari B, Başaklar AC, Kale N.

Turk J Gastroenterol. 2010 Sep;21(3):331-2. No abstract available.

36.

Diagnosis and management of giant cell arteritis: a review.

Kale N, Eggenberger E.

Curr Opin Ophthalmol. 2010 Nov;21(6):417-22. doi: 10.1097/ICU.0b013e32833eae8b. Review.

PMID:
20811283
37.

Negative appendectomy experience in children.

Karabulut R, Sonmez K, Turkyilmaz Z, Demirogullari B, Ozen IO, Demirtola A, Basaklar AC, Kale N.

Ir J Med Sci. 2011 Mar;180(1):55-8. doi: 10.1007/s11845-010-0526-y. Epub 2010 Jul 25.

PMID:
20658324
38.

Colonic phasic motor activity is stronger in patients with repaired anorectal malformations than patients with severe colonic dismotility.

Demirogullari B, Sari S, Egritas O, Karakus C, Ozen I, Sonmez K, Dalgic B, Kale N, Basaklar AC.

Pediatr Rep. 2010 Sep 6;2(2):e18. doi: 10.4081/pr.2010.e18.

40.

Apart from the other members of PDE inhibitors' family, enoximone does not enhance renal ischemic reperfusion injury: the effects of enoximone on renal ischemia reperfusion.

Pampal A, Ozen IO, Demirogullari B, Gol IH, Guclu MM, Bukan N, Poyraz A, Karabulut R, Basaklar AC, Kale N.

Ren Fail. 2009;31(10):971-6. doi: 10.3109/08860220903216873.

PMID:
20030534
41.

An ultra-sensitive DeltaR/R measurement system for biochemical sensors using piezoresistive micro-cantilevers.

Nag S, Kale NS, Rao V, Sharma DK.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3794-7. doi: 10.1109/IEMBS.2009.5334434.

PMID:
19964819
42.

Electrophysiological and clinical correlates of corpus callosum atrophy in patients with multiple sclerosis.

Kale N, Agaoglu J, Tanik O.

Neurol Res. 2010 Oct;32(8):886-90. doi: 10.1179/016164109X12445616596526. Epub 2009 Oct 12.

PMID:
19825276
43.

Humoral pattern II multiple sclerosis pathology not associated with neuromyelitis Optica IgG.

Kale N, Pittock SJ, Lennon VA, Thomsen K, Roemer S, McKeon A, Lucchinetti CF.

Arch Neurol. 2009 Oct;66(10):1298-9. doi: 10.1001/archneurol.2009.199. No abstract available.

44.

Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis.

Kale N, Agaoglu J, Onder G, Tanik O.

J Clin Neurosci. 2009 Nov;16(11):1439-42. doi: 10.1016/j.jocn.2009.03.009. Epub 2009 Aug 19.

PMID:
19695880
45.

Neuropsychiatric manifestations in multiple sclerosis: correlation of fatigue and depression with disease progression.

Kale N, Agaoglu J, Tanik O.

Neurol Res. 2010 Mar;32(2):221-3. doi: 10.1179/174313209X455664. Epub 2009 Aug 5.

PMID:
19660239
46.

Off-pump coronary artery bypass in severe left ventricular dysfunction.

Pande S, Agarwal SK, Kundu A, Kale N, Chaudhary A, Dhir U.

Asian Cardiovasc Thorac Ann. 2009 Jan;17(1):54-8. doi: 10.1177/0218492309102540.

PMID:
19515881
47.

The presentation of headache in neuro-Behçet's disease: a case-series.

Kale N, Agaoglu J, Icen M, Yazici I, Tanik O.

Headache. 2009 Mar;49(3):467-70. doi: 10.1111/j.1526-4610.2008.01265.x.

PMID:
19267789
48.

Cefoperazone induced gastro-intestinal haemorrhage. A case report.

Ozen IO, Moralioğlu S, Karabulut R, Bagbanci B, Turkyilmaz Z, Demirogullari B, Sonmez K, Basaklar AC, Kale N.

Acta Chir Belg. 2008 Nov-Dec;108(6):777-8.

PMID:
19241941
49.

Assessment of autonomic nervous system dysfunction in multiple sclerosis and association with clinical disability.

Kale N, Magana S, Agaoglu J, Tanik O.

Neurol Int. 2009 Nov 16;1(1):e5. doi: 10.4081/ni.2009.e5.

50.

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.

McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ.

Muscle Nerve. 2009 Jan;39(1):87-90. doi: 10.1002/mus.21197.

PMID:
19086079

Supplemental Content

Support Center